oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

RANIGAST

This risk may be caused by the potential presence of N-nitrosodimethylamine (NDMA) contamination in the medicinal product, which may affect human health and life. Potential effects: possible carcinogenic effect, liver damage, other toxic complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

RANIGAST
Risk Level
Critical
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Batch Number
wszystkie serie
Recall Date
19.09.2019
View official statement

Important Information

What You Should Know

Recommendations

Do not use Ranigast (Ranitidine) 0.5 mg/ml solution for infusion, check your medicine, and if in doubt consult a doctor or pharmacist to choose an alternative treatment.

Actions Taken

All batches of Ranigast (Ranitidine) 0.5 mg/ml solution for infusion were suspended from the market nationwide and the decision was given immediate enforceability, obliging the marketing authorisation...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: This risk may be caused by the potential presence of N-nitrosodimethylamine (NDMA) contamination in the medicinal product, which may affect human health and life. Potential effects: possible carcinogenic effect, liver damage, other toxic complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: wszystkie serie

Related

Other Recalled Products